VISIONARY DEAL: Bausch + Lomb, a top maker of contact lenses, is being bought for $8.7 billion by Canadian drugmaker Valeant Pharmaceuticals to expand Valeant's smaller ophthalmology business.

EYE CHART: Rochester, N. Y.-based Bausch + Lomb makes contact lenses, eye drugs and ophthalmic surgical devices. It will become a division of Valeant Pharmaceuticals International Inc. of Laval, Quebec, but will keep its better-known name and integrate Valeant's products for treating glaucoma.

THE FINE PRINT: Investment firm Warburg Pincus will receive $4.5 billion in cash. The remaining $4.2 billion will repay Bausch + Lomb's debt. The deal should close by September.


Publishing Services International Limited (PSIL) is the publisher and operator of a worldwide network of online news sites dedicated to delivering fair, accurate and relevant reporting from a variety of the world’s most trusted sources – from the biggest cities to the smallest towns.

We deliver positive and powerful messages to our readers, providing up‑to‑the‑second news that matters to the individual.

Our promise is to serve communities and individuals worldwide, delivering information that hasn’t always been available to them. We will give them back a voice – a voice that’s empowering because it is theirs – and provide a platform to communicate between themselves and the world.

We believe people are not just generic demographics; they are individuals with their own preferences and curiosities. We are about understanding these individuals, listening to them, and serving them.

We are the new pioneering spirit of news – we’re not talking to everyone, we’re talking with every one.

If you want your news, your voice, your way, on your time – we’ve got news for you.




If you have any questions or concerns please email us on


  • Australia, Toll Free 1-800-983-421
  • Hong Kong, Toll Free 800-906-187
  • Singapore, Toll Free 800-852-3871
  • USA/Canada, Toll Free 1-800-830-4132

Advertise With Us

Interested in being awesome?
Contact us by email or phone.